Concepedia

Qianqian Liu

QL

Statistics

Publications

66

Citations

2.4K

H-Index

28

Active since

2013

Affiliations

Chinese Academy of Medical Sciences & Peking Union Medical College(Current)

The University of Texas at San Antonio Health Science Center

Sichuan University

Tongji University

Shanghai Pulmonary Hospital

Qianqian Liu is an author at Chinese Academy of Medical Sciences & Peking Union Medical College specializing in medicine, life sciences, and oncology.

ORCID

Publications per year

2013–2024

66

Publications

66

A randomized control trial to establish the feasibility and safety of rapamycin treatment in an older human cohort: Immunological, physical performance, and cognitive effects

Ellen Kraig, Leslie A. Linehan, Hanyu Liang et al. · Experimental Gerontology · 2018 · 167 citations · Full text

, , +11

A specific tRNA half, 5’tiRNA-His-GTG, responds to hypoxia via the HIF1α/ANG axis and promotes colorectal cancer progression by regulating LATS2

En‐Wei Tao, Hao-Lian Wang, Wing Yin Cheng et al. · Journal of Experimental & Clinical Cancer Research · 2021 · 158 citations · Full text

, , +17

RETRACTED ARTICLE: LINC01296/miR-26a/GALNT3 axis contributes to colorectal cancer progression by regulating O-glycosylated MUC1 via PI3K/AKT pathway

Bing Liu, Shimeng Pan, Yang Xiao et al. · Journal of Experimental & Clinical Cancer Research · 2018 · 118 citations · Full text

, , +17

Targeting macrophagic SHP2 for ameliorating osteoarthritis via TLR signaling

Ziying Sun, Qianqian Liu, Zhongyang Lv et al. · Acta Pharmaceutica Sinica B · 2022 · 90 citations · Full text

, , +17

HOTAIR/miR-326/FUT6 axis facilitates colorectal cancer progression through regulating fucosylation of CD44 via PI3K/AKT/mTOR pathway

Shimeng Pan, Yanqiu Liu, Qianqian Liu et al. · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · 2019 · 83 citations

, , +16

1–5 of 66